Peer-influenced content. Sources you trust. No registration required. This is HCN.
Infectious Disease Advisor
The preservation of Medicare drug price negotiations alongside the removal of other cost-reduction measures creates a complex landscape for healthcare delivery and patient access.
All Specialties February 6th 2025
MedCentral
Delayed access to mental healthcare providers in outpatient settings risks condition deterioration, potentially leading to increased emergency department visits and hospitalizations among Medicare beneficiaries.
Geriatrics February 5th 2025
Northwestern Medicine
Neurologic manifestations of long COVID affect approximately 30% of patients regardless of vaccination status or initial disease severity, presenting significant implications for workforce productivity and healthcare delivery.
Infectious Diseases January 22nd 2025
Clinical Advisor
67.7% of adults with food allergies report psychological distress, yet fewer than 20% receive proper mental health assessment – highlighting a significant care gap in allergy management.
Allergy & Immunology January 8th 2025
GoodRx for Healthcare Professionals
The introduction of lisdexamfetamine, a generic for Vyvanse, initially showed promise in increasing access to ADHD treatment. However, it too has fallen into shortage, highlighting the ongoing challenges in meeting patient demand.
Family Medicine/General Practice September 3rd 2024
Oncology News Central (ONC)
PBMs’ vertical integration allows them to dictate cancer treatment decisions, from drug selection to delivery methods, potentially compromising patient care and increasing costs.
Hematology/Oncology July 29th 2024